litlas
Log inCreate account

Françis Lévi

Active 1982–2026

Also published as
Francis Lévi
104
Papers
23,317
Citations
75
h-index
103
i10-index

Citations

Citations per year for Françis Lévi1896: 1 citations1980: 1 citations1983: 1 citations1984: 1 citations1985: 2 citations1986: 1 citations1987: 4 citations1988: 3 citations1989: 8 citations1990: 9 citations1991: 6 citations1992: 13 citations1993: 12 citations1994: 8 citations1995: 14 citations1996: 20 citations1997: 30 citations1998: 35 citations1999: 57 citations2000: 85 citations2001: 56 citations2002: 105 citations2003: 85 citations2004: 118 citations2005: 119 citations2006: 177 citations2007: 274 citations2008: 258 citations2009: 288 citations2010: 340 citations2011: 216 citations2012: 252 citations2013: 217 citations2014: 233 citations2015: 208 citations2016: 173 citations2017: 218 citations2018: 174 citations2019: 567 citations2020: 626 citations2021: 603 citations2022: 422 citations2023: 369 citations2024: 515 citations2025: 246 citations2026: 12 citations1897–1979: no citations, so these years are not shown1981–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,855 citing papers, 25.6% of this breakdownFrance: 651 citing papers, 9% of this breakdownChina: 627 citing papers, 8.6% of this breakdownUnited Kingdom: 481 citing papers, 6.6% of this breakdownGermany: 397 citing papers, 5.5% of this breakdownItaly: 353 citing papers, 4.9% of this breakdownJapan: 248 citing papers, 3.4% of this breakdownNetherlands: 238 citing papers, 3.3% of this breakdownCanada: 211 citing papers, 2.9% of this breakdownAustralia: 180 citing papers, 2.5% of this breakdownBelgium: 176 citing papers, 2.4% of this breakdownSpain: 171 citing papers, 2.4% of this breakdown
0%25.6%Other 22.9%

Institutions

Fields

  • Medicine46.8%
  • Neuroscience23.2%
  • Immunology and Microbiology11.3%
  • Biochemistry, Genetics and Molecular Biology10.5%
  • Psychology2.2%
  • Engineering1.7%
  • Other4.3%

Topics

  • Circadian rhythm and melatonin8.6%
  • Cancer Immunotherapy and Biomarkers5%
  • Hepatocellular Carcinoma Treatment and Prognosis4.9%
  • Colorectal Cancer Treatments and Studies4.8%
  • Immunotherapy and Immune Responses4.3%
  • Dietary Effects on Health2.4%
  • Other70%

Coauthors

All papers

Open in search
  1. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

    Authors: Lionel Apétoh, François Ghiringhelli, Antoine Tesnière, Michel Obéid, Carla Ortiz, Alfredo Criollo, Grégoire Mignot, Maria Chiara Maiuri, Evelyn Ullrich, Patrick Saulnier, Huan Yang, Sebastián Amigorena, Bernard Ryffel, Franck J. Barrat, Paul Säftig, Françis Lévi, Rosette Lidereau, Catherine Noguès, Jean‐Paul Mira, Agnès Chompret, V. Joulin, Françoise Clavel‐Chapelon, Jean Bourhis, Fabrice André, Suzette Delaloge, Thomas Tursz, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2007 cited by 2,969

  2. Medicine in the Fourth Dimension

    Authors: Christopher R. Cederroth, Urs Albrecht, Joseph Bass, Steven A. Brown, Jonas Dyhrfjeld‐Johnsen, Frédéric Gachon, Carla B. Green, Michael H. Hastings, Charlotte Helfrich‐Förster, John B. Hogenesch, Françis Lévi, Andrew Loudon, Gabriella B. Lundkvist, Johanna H. Meijer, Michael Rosbash, Joseph S. Takahashi, Michael W. Young, Barbara Canlon - Cell Metabolism 2019 cited by 367

  3. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer

    Authors: Françis Lévi, Rachid Zidani, Jean-Louis Misset - The Lancet 1997 cited by 693

  4. Circadian Timing in Cancer Treatments

    Authors: Francis Lévi, Alper Okyar, Sandrine Dulong, Pasquale F. Innominato, Jean Clairambault - The Annual Review of Pharmacology and Toxicology 2010 cited by 471

  5. Circadian Regulation of Drug Responses: Toward Sex-Specific and Personalized Chronotherapy

    Authors: Françis Lévi, Alper Okyar, Éva Hadadi, Pasquale F. Innominato, Annabelle Ballesta - The Annual Review of Pharmacology and Toxicology 2023 cited by 78

  6. Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer

    Authors: Abdoulaye Karaboué, T. Collon, Ida Pavese, Viviane Bodiguel, Joël Cucherousset, Elda Zakine, Pasquale F. Innominato, Mohamed Bouchahda, René Adam, Françis Lévi - Cancers 2022 cited by 96

  7. Dosing-Time Makes the Poison: Circadian Regulation and Pharmacotherapy

    Authors: Robert Dallmann, Alper Okyar, Francis Lévi - Trends in Molecular Medicine 2016 cited by 277

  8. Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy

    Authors: René Adam, V. Delvart, Gérard Pascal, Adrian Valeanu, Denis Castaing, Daniel Azoulay, Sylvie Giacchetti, Bernard Paule, F Kunstlinger, O Ghémard, Françis Lévi, Henri Bismuth - Annals of Surgery 2004 cited by 1,474

  9. Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis

    Authors: Thierry Landré, Abdoulaye Karaboué, Zachary S. Buchwald, Pasquale F. Innominato, David C. Qian, Jean‐Baptiste Assié, C. Chouaïd, Françis Lévi, Boris Duchemann - ESMO Open 2024 cited by 78

  10. Systems Chronotherapeutics

    Authors: Annabelle Ballesta, Pasquale F. Innominato, Robert Dallmann, D.A.J. Rand, Françis Lévi - Pharmacological Reviews 2017 cited by 326

  11. Circadian Rhythms: Mechanisms and Therapeutic Implications

    Authors: Françis Lévi, Ueli Schibler - The Annual Review of Pharmacology and Toxicology 2007 cited by 601

  12. Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial

    Authors: René Adam, Céline Piedvache, L. Chiche, Jean Philippe Adam, Ephrem Salamé, Petru Bucur, Daniel Cherqui, Olivier Scatton, Victoire Granger, Michel Ducreux, Umberto Cillo, François Cauchy, Jean‐Yves Mabrut, Chris Verslype, Laurent Coubeau, Jean Hardwigsen, Emmanuel Boleslawski, Fabrice Muscari, Heithem Jeddou, Denis Pezet, Bruno Heyd, Valério Lucidi, Karen Geboes, Jan Lerut, Pietro Majno, Lamiae Grimaldi, Françis Lévi, M. Lewin, Maximiliano Gelli, Maximiliano Gelli, René Adam, René Adam, Céline Piedvache, Laurence Chiche, Jean Philippe Adam, Ephrem Salamé, Petru Bucur, Daniel Cherqui, Olivier Scatton, Victoire Granger, Michel Ducreux, Umberto Cillo, François Cauchy, Jean-Yves Mabrut, François Cauchy, Jean-Yves Mabrut, Chris Verslype, Laurent Coubeau, Jean Hardwigsen, Emmanuel Boleslawski, Fabrice Muscari, Heithem Jeddou, Denis Pezet, Bruno Heyd, Valerio Lucidi, Karen Geboes, Jan Lerut, Pietro Majno, Lamiae Grimaldi, Francis Levi, Maïté Lewin, Maximiliano Gelli, Olivier Soubrane, Mickael Lesurtel, Jean Baptsite Bachet, Samuel Lesourd, Marine Jary, Mohamed Bouattour, Sara Lonardi, Mohamed Hebbar, Karim Boudjema, Denis Smith, Mircea Chirica, Thierry Lecomte, Chirstophe Borg, Rosine Guimbaud, Julien Taieb, Patrizia Burra, Philippe Rougier, Joan Figueras - The Lancet 2024 cited by 159

  13. Why does circadian timing of administration matter for immune checkpoint inhibitors’ efficacy?

    Authors: Abdoulaye Karaboué, Pasquale F. Innominato, Nicholas I. Wreglesworth, Boris Duchemann, René Adam, Françis Lévi - British Journal of Cancer 2024 cited by 85

  14. Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group

    Authors: Sylvie Giacchetti, Georg A. Bjarnason, Carlo Garufi, Dominique Genet, Stefano Iacobelli, Marco Tampellini, Rune Smaaland, C. Focan, Bruno Coudert, Yves Humblet, Jean Luc Canon, Antoine Adenis, Giovanni Lo Re, Carlos Carvalho, Johannes Schueller, Nicole Anciaux, M.A. Lentz, Benoît Baron, Thierry Gorlia, Françis Lévi - Journal of Clinical Oncology 2006 cited by 227

  15. Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer

    Authors: Sylvie Giacchetti, B Perpoint, Rachid Zidani, N Le Bail, R. Faggiuolo, C. Focan, P. Chollet, J Llory, Yves Letourneau, Bruno Coudert, F. Bertheaut-Cvitkovic, D Larregain-Fournier, A. Le Rol, Stephen D. Walter, R. Adam, J.L. Misset, Françis Lévi - Journal of Clinical Oncology 2000 cited by 1,423

  16. The circadian timing system in clinical oncology

    Authors: Pasquale F. Innominato, Véronique Roche, Oxana Palesh, Ayhan Ulusakarya, David Spiegel, Françis Lévi - Annals of Medicine 2014 cited by 215

  17. Circadian chronotherapy for human cancers

    Authors: Françis Lévi - The Lancet Oncology 2001 cited by 257

  18. Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial

    Authors: Pasquale F. Innominato, Annabelle Ballesta, Qi Huang, C. Focan, P. Chollet, Abdoulaye Karaboué, Sylvie Giacchetti, Mohamed Bouchahda, René Adam, Carlo Garufi, Françis Lévi - Cancer Medicine 2020 cited by 68

  19. Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?

    Authors: René Adam, Dennis A. Wicherts, Robbert J. de Haas, Oriana Ciacio, Françis Lévi, Bernard Paule, Michel Ducreux, Daniel Azoulay, Henri Bismuth, Denis Castaing - Journal of Clinical Oncology 2009 cited by 587

  20. Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis

    Authors: Jimmy S. Patel, Yena Woo, Amber Draper, Caroline S. Jansen, Jennifer W. Carlisle, Pasquale F. Innominato, Françis Lévi, Layla Dhabaan, Viraj A. Master, Mehmet Asım Bilen, Mohammad K. Khan, Michael Lowe, Haydn Kissick, Zachary S. Buchwald, David C. Qian - Journal for ImmunoTherapy of Cancer 2024 cited by 32

  21. Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant Chemotherapy

    Authors: Henry Bismuth, René Adam, Françis Lévi, C Farabos, Fábio Waechter, Denis Castaing, Pietro Majno, Luc Engerran - Annals of Surgery 1996 cited by 962

  22. Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer

    Authors: Pasquale F. Innominato, C. Focan, Thierry Gorlia, Thierry Moreau, Carlo Garufi, Jim Waterhouse, Sylvie Giacchetti, Bruno Coudert, Stefano Iacobelli, Dominique Genet, Marco Tampellini, P. Chollet, M.A. Lentz, Marie‐Christine Mormont, Françis Lévi, Georg A. Bjarnason - Cancer Research 2009 cited by 249

  23. Painting, firefighting, and shiftwork

    Authors: Aaron Blair, David E. Blask, Magne Bråtveit, Thomas Brock, Jefferey L. Burgess, Giovanni Costa, S. Scott Davis, Paul A. Demers, Johnni Hansen, Erhard Haus, Philip J. Landrigan, Grace K. LeMasters, Francis Lévi, Franco Merletti, Christopher J. Portier, ­Eero Pukkala, Eva Schernhammer, Kyle Steenland, Richard G. Stevens, Roel Vermeulen, Tongzhang Zheng, Yong Zhu, Joséphine Arendt, Claire Austin, John W. Cherrie, Alicia Huici-Montagud, Kenneth A. Mundt, Andrea Altieri, Robert A. Baan, Véronique Bouvard, Vincent James Cogliano, Fabrizio Giannandrea, Fatiha El Ghissassi, Yann Grosse, Julia E. Heck, Jane Mitchell, N P Napalkov, Béatrice Secretan, Kurt Straíf, Sandrine Egraz, Michel Javin, Brigitte Kajo, Martine Lézère, Helene Lorenzen-Augros, C. Freeman, Neela Guha, Laurent Galichet, Anne Sophie Hameau - 2010 cited by 257

  24. Phase locking and multiple oscillating attractors for the coupled mammalian clock and cell cycle

    Authors: Céline Feillet, Peter Krusche, Filippo Tamanini, Roel C. Janssens, Mike Downey, Patrick Martin, Michèle Teboul, Shoko Saito, Françis Lévi, Till Bretschneider, Gijsbertus T. J. van der Horst, Franck Delaunay, D.A.J. Rand - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 214